PeriVision announces that it has partnered with the two institutions under a CHF 1.1M research grant to develop and validate novel functional eye tests for retinal diseases.
The prevalence of conditions such as age-related macular degeneration / AMD (196M) and its late-stage form geographic atrophy / GA or diabetic retinopathy / DR (146M) will dramatically increase in the coming decades due to our ageing populations and modern lifestyles according to reports by the WHO or the Lancet Global Health Commission. For instance, AMD / GA patients often perform poorly in functional eye tests due to central vision loss, fixation difficulty, or subjectivity in patient responses. This means eye doctors have a limited understanding of functional ability.
